KR102414382B1 - A method for preparing artemisia extract with a reduced content of benzopyrene - Google Patents

A method for preparing artemisia extract with a reduced content of benzopyrene Download PDF

Info

Publication number
KR102414382B1
KR102414382B1 KR1020150181739A KR20150181739A KR102414382B1 KR 102414382 B1 KR102414382 B1 KR 102414382B1 KR 1020150181739 A KR1020150181739 A KR 1020150181739A KR 20150181739 A KR20150181739 A KR 20150181739A KR 102414382 B1 KR102414382 B1 KR 102414382B1
Authority
KR
South Korea
Prior art keywords
zeolite
activated carbon
extract
benzopyrene
leachate
Prior art date
Application number
KR1020150181739A
Other languages
Korean (ko)
Other versions
KR20170073780A (en
Inventor
박상욱
임종재
김정률
김철우
장해연
송세현
손세일
이홍우
Original Assignee
대원제약주식회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 대원제약주식회사 filed Critical 대원제약주식회사
Priority to KR1020150181739A priority Critical patent/KR102414382B1/en
Publication of KR20170073780A publication Critical patent/KR20170073780A/en
Application granted granted Critical
Publication of KR102414382B1 publication Critical patent/KR102414382B1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/282Artemisia, e.g. wormwood or sagebrush
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D15/00Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/02Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material
    • B01J20/10Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material comprising silica or silicate
    • B01J20/16Alumino-silicates
    • B01J20/18Synthetic zeolitic molecular sieves
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/02Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material
    • B01J20/20Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material comprising free carbon; comprising carbon obtained by carbonising processes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

활성탄 및 제올라이트의 혼합물을 이용하여 애엽 추출물의 벤조피렌을 저감시키는 방법이 개시된다. 본 발명에 따르면 제올라이트와 활성탄을 혼합하여 처리함으로써, 위장질환 치료 약효에 대한 애엽 추출물의 지표성분 함량 및 치료 효과는 유지시키면서, 원생약 유래 또는 제조공정 중 생성될 수 있는 벤조피렌을 저감하여 효과적으로 애엽 추출물에 대한 안전성을 확보할 수 있다.Disclosed is a method for reducing benzopyrene in an extract of aerobium using a mixture of activated carbon and zeolite. According to the present invention, by mixing and processing zeolite and activated carbon, the content of the index component and the therapeutic effect of the aeyeop extract for the treatment of gastrointestinal diseases are maintained, and the benzopyrene that may be derived from the probiotic or generated during the manufacturing process is effectively reduced by reducing the aeyeop extract. safety can be ensured.

Description

벤조피렌이 저감된 애엽 추출물의 제조방법{A METHOD FOR PREPARING ARTEMISIA EXTRACT WITH A REDUCED CONTENT OF BENZOPYRENE}A method for producing a leaf extract with reduced benzopyrene {A METHOD FOR PREPARING ARTEMISIA EXTRACT WITH A REDUCED CONTENT OF BENZOPYRENE}

본 발명은 위장질환 치료제의 유효성분으로 사용되는 애엽 추출물의 제조방법에 관한 것이다. 구체적으로는, 애엽 추출물에 존재하는 유해물질인 벤조피렌을 저감하는 방법에 관한 것으로서, 활성탄과 제올라이트를 사용함으로서 유해물질인 벤조피렌이 저감된 애엽 추출물을 제조하는 방법에 관한 것이다.The present invention relates to a method for producing an aeyeop extract used as an active ingredient for a treatment for gastrointestinal diseases. More specifically, it relates to a method for reducing benzopyrene, a harmful substance present in the extract, and relates to a method for producing an extract of an ae leaf in which benzopyrene, a harmful substance, is reduced by using activated carbon and zeolite.

생약 중 유해물질에 대한 관심과 우려가 증대되고 있다. 특히, 생약 중 중금속, 잔류농약 등이 검출됨에 따라 생약 섭취의 안전성에 대한 의문이 제기되고 있다. 특히, 인삼 등의 제품에서 벤조피렌이 검출됨에 따라 생약 전반에 걸쳐서 유해물질을 제거하기 위한 수단이 연구되고 있으며, 의약품 허가기관에서도 점차 규제가 강화될 것으로 예상된다.Interest and concerns about harmful substances in herbal medicines are increasing. In particular, as heavy metals and residual pesticides in herbal medicines are detected, questions are raised about the safety of ingesting herbal medicines. In particular, as benzopyrene is detected in products such as ginseng, methods for removing harmful substances throughout herbal medicines are being studied, and regulations are expected to be gradually strengthened in drug approval institutions.

벤조피렌은 고온으로 처리되는 과정에서 탄수화물, 지방, 단백질 등이 불완전 연소할 때 주로 생성되는데, 예를 들면, 볶기, 튀김, 굽기의 가공과정에서 생성되지만, 공기, 물, 토양에 이미 잔류할 수 있기 때문에 과일이나 야채 등 가공하지 않은 식품에서도 나타나기도 한다. 가공과정 중에 발생하는 벤조피렌은 불에 가깝게 조리하거나 처리시간이 길어질수록 발생량은 증가한다고 알려져 있다. 이에 의약품 허가기관에서는 신종 유해물질인 벤조피렌의 관리방안으로서 생약의 벤조피렌 허용기준 및 시험방법에 관한 고시를 제정하였으며, 유통 생약이나 한약재 중 벤조피렌의 모니터링을 실시하는 등 관리대책을 세우고 있다. 이에 따라, 생약 중 존재하는 벤조피렌을 저감화시키는 요구가 있다.Benzopyrene is mainly produced when carbohydrates, fats, and proteins are incompletely burned during high-temperature treatment. It can also be found in unprocessed foods such as fruits and vegetables. It is known that the amount of benzopyrene generated during processing increases as cooking time close to fire or processing time increases. Accordingly, the drug approval institution has enacted a notice on benzopyrene acceptance standards and test methods for herbal medicines as a management plan for benzopyrene, a new hazardous substance, and is establishing management measures such as monitoring benzopyrene in distributed herbal or herbal medicines. Accordingly, there is a demand for reducing benzopyrene present in herbal medicines.

예를 들어, 대한민국 공개특허 제 10-2015-0085330호에서는, 유해물질의 함량을 저감시킨 위장질환 치료용 애엽 추출물의 제조방법을 개시하고 있는데, 위 특허에서는, 에탄올 또는 이소프로판올로 추출한 애엽 추출물을 애엽 잎의 중량 대비 0.1~20%(w/w) 활성탄을 사용하여 벤조피렌을 저감시키는 방법을 개시한다. 위 특허문헌에서는, 애엽 추출물을 제조하는 과정에서 활성탄을 사용하여 벤조피렌을 흡착시키는 것을 기술적 특징으로 하는데, 이에 의하면, 애엽 추출물의 유효성분이라고 알려진 유파틸린이나 자세오시딘의 함량에 변화가 없이 벤조피렌만을 선택적으로 흡착시킬 수 있다고 기재한다.For example, Korean Patent Application Laid-Open No. 10-2015-0085330 discloses a method for producing an aeyeop extract for the treatment of gastrointestinal diseases with a reduced content of harmful substances. Disclosed is a method for reducing benzopyrene by using 0.1 to 20% (w/w) activated carbon relative to the weight of the leaf. In the above patent document, the technical feature is that benzopyrene is adsorbed by using activated carbon in the process of manufacturing the aeyeop extract. It is stated that it can be selectively adsorbed.

그러나, 본 발명자의 연구에 의하면, 위 특허문헌에 기재된 방법만으로는 애엽 추출물에 존재하는 벤조피렌의 흡착율이 열악한 바, 실제 생산공정에서 보다 효율적으로 벤조피렌을 제거시킬 수 있는 새로운 방법이 요구됨을 인식하여 본 발명에 이르게 되었다.However, according to the research of the present inventor, the method described in the above patent document alone has a poor adsorption rate of benzopyrene present in the extract of a leaf extract. came to

대한민국 공개특허 제 10-2015-0085330호Republic of Korea Patent Publication No. 10-2015-0085330

본 발명에서는 애엽 추출물의 제조공정 중 활성탄과 제올라이트를 혼합하여 처리함으로써, 지표성분의 함량에 변화를 초래하지 않고 벤조피렌만을 현저히 저감시킬 수 있는 방법을 제공함을 해결과제로 한다.An object of the present invention is to provide a method capable of significantly reducing only benzopyrene without causing a change in the content of an indicator component by mixing and treating activated carbon and zeolite during the manufacturing process of the aeyeop extract.

상기 해결과제를 해결하는 기술적 수단으로서, 본 발명에서는, 제올라이트와 활성탄의 혼합물을 애엽 추출물의 중량대비 0.04~40%(w/w) 넣어 반응시키는 것을 특징으로 하는 애엽 추출물의 벤조피렌 저감방법이 개시된다. 또한, 상기 벤조피렌 저감방법을 이용하는 것을 포함하는 애엽 추출물의 제조방법이 개시된다.As a technical means to solve the above problem, in the present invention, a method for reducing benzopyrene in ayeop extract is disclosed, characterized in that a mixture of zeolite and activated carbon is added and reacted by adding 0.04 to 40% (w/w) based on the weight of the aeyeop extract. . In addition, there is disclosed a method for producing ayeop extract comprising using the benzopyrene reduction method.

본 발명에 의하면, 애엽 추출물 중 지표성분인 유파틸린이나 자세오시딘의 함량에 변화를 초래하지 않고, 유해물질인 벤조피렌만을 선택적으로 흡착시킬 수 있으며, 특히, 활성탄을 단독으로 사용하였을 때 보다 벤조피렌의 선택적 흡착률이 현저하게 상승한다.According to the present invention, it is possible to selectively adsorb only benzopyrene, which is a harmful substance, without causing a change in the content of eupatylin or zeosidine, which are index components, in the extract of the leaf extract. The selective adsorption rate is significantly increased.

도 1 및 2는 제올라이트와 활성탄의 혼합물을 처리한 것과 처리하지 않은 것의 추출물의 성분 프로파일을 확인하는 도이다.1 and 2 are diagrams confirming the component profile of the extract of the treated and not treated with a mixture of zeolite and activated carbon.

벤조피렌에 단기 노출되면 임신 중 기형유발, 면역억제 반응이 일어나며 장기노출시 피부접촉, 흡입, 기관내 및 기관지 투여, 피하 또는 근육 주사, 그 밖의 다른 사용에 의해 동물들에게 국소적인 발암성을 유발한다고 알려져 있다. 수컷 F344 래트에 경구투여 하자 급성독성 실험에서 백혈구 감소와 평균 세포-헤모글로빈 농도 증가를 보였다. 또한, 체중에 대한 간 무게 비율이 최대 30%까지 증가하였다. 만성 독성실험에서 체중의 감소와 체중에 대한 간 비율 증가를 보였으며, 고용량 투여군에서는 신장의 비정상성 및 화학적 요소 중 BUN이 증가하였다. (Knuckles et al., 2001) 또한, US EPA는 벤조피렌을 인간에게서 발암성이 있을 것으로 보아 B2로 분류하였으며, 다수의 동물실험에서 발암성이 입증되었다.Short-term exposure to benzopyrene may cause teratogenic and immunosuppressive reactions during pregnancy, and long-term exposure may cause local carcinogenicity in animals by skin contact, inhalation, intratracheal and bronchial administration, subcutaneous or intramuscular injection, and other uses. is known Oral administration to male F344 rats showed a decrease in leukocytes and an increase in mean cell-hemoglobin concentration in an acute toxicity study. In addition, the liver weight to body weight ratio increased by up to 30%. The chronic toxicity test showed a decrease in body weight and an increase in the liver-to-weight ratio, and in the high-dose group, abnormalities in the kidneys and BUN among chemical factors increased. (Knuckles et al., 2001) In addition, the US EPA classified benzopyrene as B2 because it is thought to be carcinogenic to humans, and it has been proven carcinogenic in a number of animal experiments.

쑥(Artemisia mongolica, A. asiatica, A. princeps var. orientalis, A. argyi, A. montana 등)은 국화과에 속하는 다년생 약초로서 예로부터 강장보혈, 부인병, 설사치료제로 사용되어 왔으며, 규명된 화학성분으로서 이소쿠마린, 쿠마린, 디테르펜락톤 등이 있으며, 유파틸린, 자세오시딘 등의 플라보이노이드 성분 등도 확인되었다. 대한약전외 한약(생약)규격집에서는 상기 쑥의 잎 및 어린 줄기를 일컬어 애엽(艾葉, Artemisiae argyi Herb)이라 지칭하고 있다. 이 중 플라보노이드 성분인 유파틸린(eupatilin)은 항알러지 효과(일본 공개특허공보 소59-155314호)가 알려진 바 있으며 국내에서도 위장질환 치료제로서의 효용성에 대해서도 밝혀진 바 있다.(대한민국 특허등록 127777) 더불어, 또 다른 플라보노이드 성분인 자세오시딘(jaseocidin) 역시 동일한 위장질환 치료제로서 사용 가능함이 특허로 등록된 바 있다. (대한민국 특허등록 181751)본 발명에서는, 상기 애엽 추출물을 제조함에 있어서, 애엽을 에탄올 또는 이소프로판올로 추출하여 얻은 애엽 추출물에 제올라이트와 활성탄의 혼합물을 넣어 교반 여과하거나, 또는, 상기 혼합물을 컬럼에 충진하여 사용함으로써, 애엽 추출물 중에 존재하는 벤조피렌을 선택적으로 제거하는 것을 특징으로 한다. Mugwort (Artemisia mongolica, A. asiatica, A. princeps var. orientalis, A. argyi, A. montana, etc.) is a perennial herb belonging to the Asteraceae family and has been used as a tonic blood, gynecological disease, and diarrhea treatment since ancient times. As such, there are isocoumarin, coumarin, diterpene lactone, and the like, and flavonoid components such as eupatylline and zeosidine were also confirmed. In addition to the Korean Pharmacopoeia, the herbal medicine (herbal medicine) standard is referred to as aeyeop (艾葉, Artemisiae argyi Herb) as the leaves and young stems of the mugwort. Among them, eupatilin, a flavonoid component, is known for its anti-allergic effect (Japanese Patent Application Laid-Open No. 59-155314), and its efficacy as a treatment for gastrointestinal diseases has also been revealed in Korea (Korean Patent Registration 127777). Another flavonoid component, jaseocidin, has also been registered as a patent for use as a treatment for the same gastrointestinal disease. (Korea Patent Registration 181751) In the present invention, in the preparation of the ayeop extract, a mixture of zeolite and activated carbon is added to the aeyeop extract obtained by extracting the ayeop extract with ethanol or isopropanol, and the mixture is stirred and filtered, or the mixture is filled in a column By using it, it is characterized in that it selectively removes benzopyrene present in the leaf extract.

본 발명에 따르면 제올라이트와 활성탄을 혼합하여 처리함으로써, 위장질환 치료 약효에 대한 애엽 추출물의 지표성분 함량 및 치료 효과는 유지시키면서, 원생약 유래 또는 제조공정 중 생성될 수 있는 벤조피렌을 저감하여 효과적으로 애엽 추출물에 대한 안전성을 확보할 수 있다.According to the present invention, by mixing and processing zeolite and activated carbon, the content of the index component and the therapeutic effect of the aeyeop extract for the treatment of gastrointestinal diseases are maintained, and the benzopyrene that may be derived from the probiotic or generated during the manufacturing process is effectively reduced by reducing the aeyeop extract. safety can be ensured.

이때, 활성탄과 제올라이트의 혼합비는 1:5 내지 5:1이 될 수 있으며, 1:1로 혼합하여 사용하는 것이 바람직하다.At this time, the mixing ratio of activated carbon and zeolite may be 1:5 to 5:1, and it is preferable to use it by mixing 1:1.

활성탄은 주 성분이 탄소이며 다공성이므로, 표면적이 넓어 흡착성이 강하고, 화학 반응이 빨리 일어나는 물질이다. 본 발명에서는 벤조피렌만을 선택적으로 흡착하면서도 지표성분(유파틸린, 자세오시딘)은 흡착하지 않아야 하는데, 이를 위해서는 비표면적 600m2/g 이상, 평균입경 149um 이하(100mesh이상)인 활성탄을 사용하는 것이 바람직하다. Activated carbon is a material whose main component is carbon and is porous, so it has a large surface area, has strong adsorption, and a chemical reaction occurs quickly. In the present invention, while selectively adsorbing only benzopyrene, indicator components ( eupatylin , zeosidine) should not be adsorbed. do.

제올라이트는, 결정질 알루미늄 규산염 광물로서, 그 결정구조 내에 있는 양이온의 작용에 의해 불포화 탄화수소나 극성물질을 선택적으로 강하게 흡착하는 성질을 가지며, 또한, 일정한 크기의 세공직경을 가지고 있기 때문에 이것보다 작은 분자를 선택적으로 통과시켜 흡착할 수 있다. 본 발명에서 사용하는 제올라이트는 비표면적 200m2/g 이상, 미세세공 면적 120m2/g 이상 및 Si/Al 분자비 2.5 이상인 것을 이용하는 것이 바람직하다.Zeolite, as a crystalline aluminum silicate mineral, has the property of selectively and strongly adsorbing unsaturated hydrocarbons or polar substances by the action of cations in its crystal structure, and also has a pore diameter of a certain size. It can be selectively passed through and adsorbed. The zeolite used in the present invention preferably has a specific surface area of 200 m 2 /g or more, a micropore area of 120 m 2 /g or more, and a Si/Al molecular ratio of 2.5 or more.

본 발명에서는 활성탄과 제올라이트의 혼합물을 이용한다. 즉, 본 발명자의 연구에 의하면, 활성탄은 벤조피렌 저감 효과가 뛰어나지만 20%를 초과하여 사용할 경우에는 지표성분의 함량변화가 큰 것으로 나타난 바, 지표성분의 함량변화 없이 벤조피렌을 현저히 제거할 수 없다는 문제점이 있다. 반면, 제올라이트는 벤조피렌 제거 효과는 활성탄에 비해 낮지만 지표성분 함량에는 큰 영향을 미치지 않음을 발견하였다. 본 발명에서는 활성탄과 제올라이트를 혼합하여 처리함으로써, 지표성분의 큰 함량변화 없이도 벤조피렌을 현저히 저감하는 방법을 제시한다. 이하, 실시예를 통해서 본 발명을 설명한다. In the present invention, a mixture of activated carbon and zeolite is used. That is, according to the present inventor's study, activated carbon has an excellent effect of reducing benzopyrene, but when it is used in excess of 20%, the content change of the indicator component is large. There is this. On the other hand, it was found that zeolite had a lower benzopyrene removal effect than activated carbon, but did not significantly affect the index component content. In the present invention, by mixing and treating activated carbon and zeolite, a method for remarkably reducing benzopyrene without a large content change in the indicator component is proposed. Hereinafter, the present invention will be described by way of Examples.

비교예 1) 제올라이트 또는 활성탄을 처리하지 않은 추출물의 제조Comparative Example 1) Preparation of extracts not treated with zeolite or activated carbon

세절한 애엽 100g을 100% 이소프로판올 1,700ml으로 상온에서 24시간 냉침하여 여과한 후(1차 침출액), 잔류물을 100% 이소프로판올 700ml에 넣어 24시간 냉침하여 여과하였다(2차 침출액). 1차 침출액과 2차 침출액을 합하여 감압농축하여 240ml의 1차 농축액을 얻었다. 1차 농축액을 여과한 후, 감압농축하여 약 5g의 연조엑스를 얻었다.100 g of chopped ae leaves were cooled with 1,700 ml of 100% isopropanol at room temperature for 24 hours and filtered (first leachate). The primary leachate and the secondary leachate were combined and concentrated under reduced pressure to obtain 240ml of the primary concentrate. After filtering the primary concentrate, it was concentrated under reduced pressure to obtain about 5 g of soft crude extract.

비교예 2) 제올라이트 0.02%를 처리한 추출물의 제조Comparative Example 2) Preparation of extract treated with zeolite 0.02%

세절한 애엽 100g을 100% 이소프로판올 1,700ml으로 상온에서 24시간 냉침하여 여과한 후(1차 침출액), 잔류물을 100% 이소프로판올 700ml에 넣어 24시간 냉침하여 여과하였다(2차 침출액). 1차 침출액과 2차 침출액을 합하여 감압농축하여 240ml의 1차 농축액을 얻었다. 1차 농축액에 제올라이트 0.02g을 넣고 4시간 교반하여 여과한 후, 감압농축하여 약 5g의 연조엑스를 얻었다. 제올라이트는 비표면적 403m2/g, 미세세공 면적 241m2/g, Si/Al 분자비 25인 제올라이트를 사용하였다.100 g of minced ae leaves were cooled with 1,700 ml of 100% isopropanol at room temperature for 24 hours and filtered (first leachate). The primary leachate and the secondary leachate were combined and concentrated under reduced pressure to obtain 240ml of the primary concentrate. 0.02 g of zeolite was added to the primary concentrate, stirred for 4 hours, filtered, and then concentrated under reduced pressure to obtain about 5 g of soft crude extract. As the zeolite, a zeolite having a specific surface area of 403 m 2 /g, a micropore area of 241 m 2 /g, and a Si/Al molecular ratio of 25 was used.

비교예 3) 제올라이트 0.2%를 처리한 추출물의 제조Comparative Example 3) Preparation of extract treated with zeolite 0.2%

세절한 애엽 100g을 100% 이소프로판올 1,700ml으로 상온에서 24시간 냉침하여 여과한 후(1차 침출액), 잔류물을 100% 이소프로판올 700ml에 넣어 24시간 냉침하여 여과하였다(2차 침출액). 1차 침출액과 2차 침출액을 합하여 감압농축하여 240ml의 1차 농축액을 얻었다. 1차 농축액에 제올라이트 0.2g을 넣고 4시간 교반하여 여과한 후, 감압농축하여 약 5g의 연조엑스를 얻었다. 제올라이트는 비표면적 403m2/g, 미세세공 면적 241m2/g, Si/Al 분자비 25인 제올라이트를 사용하였다.100 g of minced ae leaves were cooled with 1,700 ml of 100% isopropanol at room temperature for 24 hours and filtered (first leachate). The primary leachate and the secondary leachate were combined and concentrated under reduced pressure to obtain 240ml of the primary concentrate. 0.2 g of zeolite was added to the primary concentrate, stirred for 4 hours, filtered, and then concentrated under reduced pressure to obtain about 5 g of soft crude extract. As the zeolite, a zeolite having a specific surface area of 403 m 2 /g, a micropore area of 241 m 2 /g, and a Si/Al molecular ratio of 25 was used.

비교예 4) 제올라이트 2%를 처리한 추출물의 제조Comparative Example 4) Preparation of extract treated with zeolite 2%

세절한 애엽 100g을 100% 이소프로판올 1,700ml으로 상온에서 24시간 냉침하여 여과한 후(1차 침출액), 잔류물을 100% 이소프로판올 700ml에 넣어 24시간 냉침하여 여과하였다(2차 침출액). 1차 침출액과 2차 침출액을 합하여 감압농축하여 240ml의 1차 농축액을 얻었다. 1차 농축액에 제올라이트 2g을 넣고 4시간 교반하여 여과한 후, 감압농축하여 약 5g의 연조엑스를 얻었다. 제올라이트는 비표면적 403m2/g, 미세세공 면적 241m2/g, Si/Al 분자비 25인 제올라이트를 사용하였다.100 g of chopped ae leaves were cooled with 1,700 ml of 100% isopropanol at room temperature for 24 hours and filtered (first leachate). The primary leachate and the secondary leachate were combined and concentrated under reduced pressure to obtain 240ml of the primary concentrate. 2 g of zeolite was added to the primary concentrate, stirred for 4 hours, filtered, and then concentrated under reduced pressure to obtain about 5 g of soft crude extract. As the zeolite, a zeolite having a specific surface area of 403 m 2 /g, a micropore area of 241 m 2 /g, and a Si/Al molecular ratio of 25 was used.

비교예 5) 제올라이트 20%를 처리한 추출물의 제조Comparative Example 5) Preparation of extract treated with 20% zeolite

세절한 애엽 100g을 100% 이소프로판올 1,700ml으로 상온에서 24시간 냉침하여 여과한 후(1차 침출액), 잔류물을 100% 이소프로판올 700ml에 넣어 24시간 냉침하여 여과하였다(2차 침출액). 1차 침출액과 2차 침출액을 합하여 감압농축하여 240ml의 1차 농축액을 얻었다. 1차 농축액에 제올라이트 20g을 넣고 4시간 교반하여 여과한 후, 감압농축하여 약 5g의 연조엑스를 얻었다. 제올라이트는 비표면적 403m2/g, 미세세공 면적 241m2/g, Si/Al 분자비 25인 제올라이트를 사용하였다.100 g of chopped ae leaves were cooled with 1,700 ml of 100% isopropanol at room temperature for 24 hours and filtered (first leachate). The primary leachate and the secondary leachate were combined and concentrated under reduced pressure to obtain 240ml of the primary concentrate. 20 g of zeolite was added to the first concentrate, stirred for 4 hours, filtered, and then concentrated under reduced pressure to obtain about 5 g of soft crude extract. As the zeolite, a zeolite having a specific surface area of 403 m 2 /g, a micropore area of 241 m 2 /g, and a Si/Al molecular ratio of 25 was used.

비교예 6) 제올라이트 40%를 처리한 추출물의 제조Comparative Example 6) Preparation of an extract treated with 40% zeolite

세절한 애엽 100g을 100% 이소프로판올 1,700ml으로 상온에서 24시간 냉침하여 여과한 후(1차 침출액), 잔류물을 100% 이소프로판올 700ml에 넣어 24시간 냉침하여 여과하였다(2차 침출액). 1차 침출액과 2차 침출액을 합하여 감압농축하여 240ml의 1차 농축액을 얻었다. 1차 농축액에 제올라이트 40g을 넣고 4시간 교반하여 여과한 후, 감압농축하여 약 5g의 연조엑스를 얻었다. 제올라이트는 비표면적 403m2/g, 미세세공 면적 241m2/g, Si/Al 분자비 25인 제올라이트를 사용하였다.100 g of minced ae leaves were cooled with 1,700 ml of 100% isopropanol at room temperature for 24 hours and filtered (first leachate). The primary leachate and the secondary leachate were combined and concentrated under reduced pressure to obtain 240ml of the primary concentrate. 40 g of zeolite was added to the first concentrate, stirred for 4 hours, filtered, and then concentrated under reduced pressure to obtain about 5 g of soft crude extract. As the zeolite, a zeolite having a specific surface area of 403 m 2 /g, a micropore area of 241 m 2 /g, and a Si/Al molecular ratio of 25 was used.

비교예 7) 활성탄 0.02%를 처리한 추출물의 제조Comparative Example 7) Preparation of extract treated with activated carbon 0.02%

세절한 애엽 100g을 100% 이소프로판올 1,700ml으로 상온에서 24시간 냉침하여 여과한 후(1차 침출액), 잔류물을 100% 이소프로판올 700ml에 넣어 24시간 냉침하여 여과하였다(2차 침출액). 1차 침출액과 2차 침출액을 합하여 감압농축하여 240ml의 1차 농축액을 얻었다. 1차 농축액에 활성탄 0.02g을 넣고 4시간 교반하여 여과한 후, 감압농축하여 약 5g의 연조엑스를 얻었다. 활성탄은 비표면적 1,200m2/g, 입경 74um 이하(200mesh 이상)인 활성탄을 사용하였다.100 g of minced ae leaves were cooled with 1,700 ml of 100% isopropanol at room temperature for 24 hours and filtered (first leachate). The primary leachate and the secondary leachate were combined and concentrated under reduced pressure to obtain 240ml of the primary concentrate. 0.02 g of activated carbon was added to the primary concentrate, stirred for 4 hours, filtered, and then concentrated under reduced pressure to obtain about 5 g of soft crude extract. Activated carbon having a specific surface area of 1,200 m 2 /g and a particle size of 74um or less (200mesh or more) was used.

비교예 8) 활성탄 0.2%를 처리한 추출물의 제조Comparative Example 8) Preparation of extract treated with activated carbon 0.2%

세절한 애엽 100g을 100% 이소프로판올 1,700ml으로 상온에서 24시간 냉침하여 여과한 후(1차 침출액), 잔류물을 100% 이소프로판올 700ml에 넣어 24시간 냉침하여 여과하였다(2차 침출액). 1차 침출액과 2차 침출액을 합하여 감압농축하여 240ml의 1차 농축액을 얻었다. 1차 농축액에 활성탄 0.2g을 넣고 4시간 교반하여 여과한 후, 감압농축하여 약 5g의 연조엑스를 얻었다. 활성탄은 비표면적 1,200m2/g, 입경 74um 이하(200mesh 이상)인 활성탄을 사용하였다.100 g of minced ae leaves were cooled with 1,700 ml of 100% isopropanol at room temperature for 24 hours and filtered (first leachate). The primary leachate and the secondary leachate were combined and concentrated under reduced pressure to obtain 240ml of the primary concentrate. 0.2 g of activated carbon was added to the primary concentrate, stirred for 4 hours, filtered, and then concentrated under reduced pressure to obtain about 5 g of soft crude extract. Activated carbon having a specific surface area of 1,200 m 2 /g and a particle size of 74um or less (200mesh or more) was used.

비교예 9) 활성탄 2%를 처리한 추출물의 제조Comparative Example 9) Preparation of extract treated with activated carbon 2%

세절한 애엽 100g을 100% 이소프로판올 1,700ml으로 상온에서 24시간 냉침하여 여과한 후(1차 침출액), 잔류물을 100% 이소프로판올 700ml에 넣어 24시간 냉침하여 여과하였다(2차 침출액). 1차 침출액과 2차 침출액을 합하여 감압농축하여 240ml의 1차 농축액을 얻었다. 1차 농축액에 활성탄 2g을 넣고 4시간 교반하여 여과한 후, 감압농축하여 약 5g의 연조엑스를 얻었다. 활성탄은 비표면적 1,200m2/g, 입경 74um 이하(200mesh 이상)인 활성탄을 사용하였다.100 g of chopped ae leaves were cooled with 1,700 ml of 100% isopropanol at room temperature for 24 hours and filtered (first leachate). The primary leachate and the secondary leachate were combined and concentrated under reduced pressure to obtain 240ml of the primary concentrate. 2 g of activated carbon was added to the primary concentrate, stirred for 4 hours, filtered, and then concentrated under reduced pressure to obtain about 5 g of soft crude extract. Activated carbon having a specific surface area of 1,200 m 2 /g and a particle size of 74um or less (200mesh or more) was used.

비교예 10) 활성탄 10%를 처리한 추출물의 제조Comparative Example 10) Preparation of extract treated with 10% activated carbon

세절한 애엽 100g을 100% 이소프로판올 1,700ml으로 상온에서 24시간 냉침하여 여과한 후(1차 침출액), 잔류물을 100% 이소프로판올 700ml에 넣어 24시간 냉침하여 여과하였다(2차 침출액). 1차 침출액과 2차 침출액을 합하여 감압농축하여 240ml의 1차 농축액을 얻었다. 1차 농축액에 활성탄 10g을 넣고 4시간 교반하여 여과한 후, 감압농축하여 약 5g의 연조엑스를 얻는다. 활성탄은 비표면적 1,200m2/g, 입경 74um 이하(200mesh 이상)인 활성탄을 사용하였다.100 g of chopped ae leaves were cooled with 1,700 ml of 100% isopropanol at room temperature for 24 hours and filtered (first leachate). The primary leachate and the secondary leachate were combined and concentrated under reduced pressure to obtain 240ml of the primary concentrate. 10 g of activated carbon is added to the primary concentrate, stirred for 4 hours, filtered, and then concentrated under reduced pressure to obtain about 5 g of soft shell extract. Activated carbon having a specific surface area of 1,200 m 2 /g and a particle size of 74um or less (200mesh or more) was used.

비교예 11) 활성탄 40%를 처리한 추출물의 제조Comparative Example 11) Preparation of an extract treated with 40% activated carbon

세절한 애엽 100g을 100% 이소프로판올 1,700ml으로 상온에서 24시간 냉침하여 여과한 후(1차 침출액), 잔류물을 100% 이소프로판올 700ml에 넣어 24시간 냉침하여 여과하였다(2차 침출액). 1차 침출액과 2차 침출액을 합하여 감압농축하여 240ml의 1차 농축액을 얻었다. 1차 농축액에 활성탄 40g을 넣고 4시간 교반하여 여과한 후, 감압농축하여 약 5g의 연조엑스를 얻었다. 활성탄은 비표면적 1,200m2/g, 입경 74um 이하(200mesh 이상)인 활성탄을 사용하였다.100 g of minced ae leaves were cooled with 1,700 ml of 100% isopropanol at room temperature for 24 hours and filtered (first leachate). The primary leachate and the secondary leachate were combined and concentrated under reduced pressure to obtain 240ml of the primary concentrate. 40 g of activated carbon was added to the first concentrate, stirred for 4 hours, filtered, and then concentrated under reduced pressure to obtain about 5 g of soft crude extract. Activated carbon having a specific surface area of 1,200 m 2 /g and a particle size of 74um or less (200mesh or more) was used.

비교예 12) 제올라이트, 활성탄 혼합물 80%를 처리한 추출물의 제조Comparative Example 12) Preparation of extract treated with 80% of a mixture of zeolite and activated carbon

세절한 애엽 100g을 100% 이소프로판올 1,700ml으로 상온에서 24시간 냉침하여 여과한 후(1차 침출액), 잔류물을 100% 이소프로판올 700ml에 넣어 24시간 냉침하여 여과하였다(2차 침출액). 1차 침출액과 2차 침출액을 합하여 감압농축하여 240ml의 1차 농축액을 얻었다. 1차 농축액에 제올라이트, 활성탄 혼합물(제올라이트 : 활성탄 = 1 : 1) 80g을 넣고 4시간 교반하여 여과한 후, 감압농축하여 약 5g의 연조엑스를 얻었다. 제올라이트는 비표면적 403m2/g, 미세세공 면적 241m2/g, Si/Al 분자비 25인 제올라이트를 사용하였다. 활성탄은 비표면적 1,200m2/g, 입경 74um 이하(200mesh 이상)인 활성탄을 사용하였다.100 g of minced ae leaves were cooled with 1,700 ml of 100% isopropanol at room temperature for 24 hours and filtered (first leachate). The primary leachate and the secondary leachate were combined and concentrated under reduced pressure to obtain 240ml of the primary concentrate. 80 g of a mixture of zeolite and activated carbon (zeolite: activated carbon = 1:1) was added to the primary concentrate, stirred for 4 hours, filtered, and then concentrated under reduced pressure to obtain about 5 g of soft crude extract. As the zeolite, a zeolite having a specific surface area of 403 m 2 /g, a micropore area of 241 m 2 /g, and a Si/Al molecular ratio of 25 was used. Activated carbon having a specific surface area of 1,200 m 2 /g and a particle size of 74um or less (200mesh or more) was used.

비교예 13) 원생약을 세척한 추출물의 제조Comparative Example 13) Preparation of extracts washed with protozoa

세절한 애엽 100g을 미온수에 담가 세척한 후, 40℃에서 송풍 건조 시킨다. 건조된 애엽을 100% 이소프로판올 1,700ml으로 상온에서 24시간 냉침하여 여과한 후(1차 침출액), 잔류물을 100% 이소프로판올 700ml에 넣어 24시간 냉침하여 여과하였다(2차 침출액). 1차 침출액과 2차 침출액을 합하여 감압농축하여 240ml의 1차 농축액을 얻었다. 1차 농축액을 여과한 후, 감압농축하여 약 5g의 연조엑스를 얻었다.100g of chopped ae leaves are soaked in lukewarm water, washed, and blow-dried at 40°C. The dried ae leaves were cooled with 1,700 ml of 100% isopropanol at room temperature for 24 hours and filtered (first leachate). The primary leachate and the secondary leachate were combined and concentrated under reduced pressure to obtain 240ml of the primary concentrate. After filtering the primary concentrate, it was concentrated under reduced pressure to obtain about 5 g of soft crude extract.

비교예 14) 원생약을 세척한 후, 활성탄 0.2%를 처리한 추출물의 제조Comparative Example 14) Preparation of extract treated with 0.2% activated carbon after washing the protozoan

세절한 애엽 100g을 미온수에 담가 세척한 후, 40℃에서 송풍 건조 시킨다. 건조된 애엽을 100% 이소프로판올 1,700ml으로 상온에서 24시간 냉침하여 여과한 후(1차 침출액), 잔류물을 100% 이소프로판올 700ml에 넣어 24시간 냉침하여 여과하였다(2차 침출액). 1차 침출액과 2차 침출액을 합하여 감압농축하여 240ml의 1차 농축액을 얻었다. 1차 농축액에 활성탄 0.2g을 넣고 4시간 교반하여 여과한 후, 감압농축하여 약 5g의 연조엑스를 얻었다. 활성탄은 비표면적 1,200m2/g, 입경 74um 이하(200mesh 이상)인 활성탄을 사용하였다.100g of chopped ae leaves are soaked in lukewarm water, washed, and blow-dried at 40°C. The dried ae leaves were cooled with 1,700 ml of 100% isopropanol at room temperature for 24 hours and filtered (first leachate). The primary leachate and the secondary leachate were combined and concentrated under reduced pressure to obtain 240ml of the primary concentrate. 0.2 g of activated carbon was added to the primary concentrate, stirred for 4 hours, filtered, and then concentrated under reduced pressure to obtain about 5 g of soft crude extract. Activated carbon having a specific surface area of 1,200 m 2 /g and a particle size of 74um or less (200mesh or more) was used.

비교예 15) 제올라이트 0.2%를 처리한 추출물의 제조Comparative Example 15) Preparation of extract treated with zeolite 0.2%

세절한 애엽 100g을 100% 이소프로판올 1,700ml으로 상온에서 24시간 냉침하여 여과한 후(1차 침출액), 잔류물을 100% 이소프로판올 700ml에 넣어 24시간 냉침하여 여과하였다(2차 침출액). 1차 침출액과 2차 침출액을 합하여 감압농축하여 240ml의 1차 농축액을 얻었다 1차 농축액에 제올라이트 0.2g을 넣고 4시간 교반하여 여과한 후, 감압농축하여 약 5g의 연조엑스를 얻었다. 제올라이트는 비표면적 198m2/g, 미세세공 면적 116m2/g, Si/Al 분자비 2인 제올라이트를 사용하였다.100 g of minced ae leaves were cooled with 1,700 ml of 100% isopropanol at room temperature for 24 hours and filtered (first leachate). The primary and secondary leachates were combined and concentrated under reduced pressure to obtain 240 ml of a primary concentrate. To the primary concentrate, 0.2 g of zeolite was added, stirred for 4 hours, filtered, and concentrated under reduced pressure to obtain about 5 g of soft crude extract. As the zeolite, a zeolite having a specific surface area of 198 m 2 /g, a micropore area of 116 m 2 /g, and a Si/Al molecular ratio of 2 was used.

비교예 16) 활성탄 0.2%를 처리한 추출물의 제조Comparative Example 16) Preparation of extract treated with activated carbon 0.2%

세절한 애엽 100g을 100% 이소프로판올 1,700ml으로 상온에서 24시간 냉침하여 여과한 후(1차 침출액), 잔류물을 100% 이소프로판올 700ml에 넣어 24시간 냉침하여 여과하였다(2차 침출액). 1차 침출액과 2차 침출액을 합하여 감압농축하여 240ml의 1차 농축액을 얻었다. 1차 농축액에 활성탄 0.2g을 넣고 4시간 교반하여 여과한 후, 감압농축하여 약 5g의 연조엑스를 얻었다. 활성탄은 비표면적 580m2/g, 입경 177um 이하(80mesh 이상)인 활성탄을 사용하였다.100 g of chopped ae leaves were cooled with 1,700 ml of 100% isopropanol at room temperature for 24 hours and filtered (first leachate). The primary leachate and the secondary leachate were combined and concentrated under reduced pressure to obtain 240ml of the primary concentrate. 0.2 g of activated carbon was added to the primary concentrate, stirred for 4 hours, filtered, and then concentrated under reduced pressure to obtain about 5 g of soft crude extract. Activated carbon having a specific surface area of 580 m 2 /g and a particle size of 177 μm or less (80 mesh or more) was used as the activated carbon.

비교예 17) 제올라이트, 활성탄 혼합물 0.4%를 처리한 추출물의 제조Comparative Example 17) Preparation of extract treated with zeolite and activated carbon mixture 0.4%

세절한 애엽 100g을 100% 이소프로판올 1,700ml으로 상온에서 24시간 냉침하여 여과한 후(1차 침출액), 잔류물을 100% 이소프로판올 700ml에 넣어 24시간 냉침하여 여과하였다(2차 침출액). 1차 침출액과 2차 침출액을 합하여 감압농축하여 240ml의 1차 농축액을 얻었다. 1차 농축액에 제올라이트, 활성탄 혼합물(제올라이트 : 활성탄 = 1 : 1) 0.4g을 넣고 4시간 교반하여 여과한 후, 감압농축하여 약 5g의 연조엑스를 얻었다. 제올라이트는 비표면적 198m2/g, 미세세공 면적 116m2/g, Si/Al 분자비 2인 제올라이트를 사용하였다. 활성탄은 비표면적 580m2/g, 입경 177um 이하(80mesh 이상)인 활성탄을 사용하였다.100 g of minced ae leaves were cooled with 1,700 ml of 100% isopropanol at room temperature for 24 hours and filtered (first leachate). The primary leachate and the secondary leachate were combined and concentrated under reduced pressure to obtain 240ml of the primary concentrate. 0.4 g of a mixture of zeolite and activated carbon (zeolite: activated carbon = 1:1) was added to the primary concentrate, stirred for 4 hours, filtered, and then concentrated under reduced pressure to obtain about 5 g of soft crude extract. As the zeolite, a zeolite having a specific surface area of 198 m 2 /g, a micropore area of 116 m 2 /g, and a Si/Al molecular ratio of 2 was used. Activated carbon having a specific surface area of 580 m 2 /g and a particle size of 177 μm or less (80 mesh or more) was used as the activated carbon.

실시예 1) 제올라이트, 활성탄 혼합물 0.04%를 처리한 추출물의 제조Example 1) Preparation of extract treated with zeolite and activated carbon mixture 0.04%

세절한 애엽 100g을 100% 이소프로판올 1,700ml으로 상온에서 24시간 냉침하여 여과한 후(1차 침출액), 잔류물을 100% 이소프로판올 700ml에 넣어 24시간 냉침하여 여과하였다(2차 침출액). 1차 침출액과 2차 침출액을 합하여 감압농축하여 240ml의 1차 농축액을 얻었다. 1차 농축액에 제올라이트, 활성탄 혼합물(제올라이트 : 활성탄 = 1 : 1) 0.04g을 넣고 4시간 교반하여 여과한 후, 감압농축하여 약 5g의 연조엑스를 얻었다. 제올라이트는 비표면적 403m2/g, 미세세공 면적 241m2/g, Si/Al 분자비 25인 제올라이트를 사용하였다. 활성탄은 비표면적 1,200m2/g, 입경 74um 이하(200 mesh 이상)인 활성탄을 사용하였다.100 g of minced ae leaves were cooled with 1,700 ml of 100% isopropanol at room temperature for 24 hours and filtered (first leachate). The primary leachate and the secondary leachate were combined and concentrated under reduced pressure to obtain 240ml of the primary concentrate. 0.04 g of a mixture of zeolite and activated carbon (zeolite: activated carbon = 1:1) was added to the primary concentrate, stirred for 4 hours, filtered, and then concentrated under reduced pressure to obtain about 5 g of soft crude extract. As the zeolite, a zeolite having a specific surface area of 403 m 2 /g, a micropore area of 241 m 2 /g, and a Si/Al molecular ratio of 25 was used. Activated carbon having a specific surface area of 1,200 m 2 /g and a particle diameter of 74 μm or less (200 mesh or more) was used as the activated carbon.

실시예 2) 제올라이트, 활성탄 혼합물 0.4%를 처리한 추출물의 제조Example 2) Preparation of extract treated with zeolite and activated carbon mixture 0.4%

세절한 애엽 100g을 100% 이소프로판올 1,700ml으로 상온에서 24시간 냉침하여 여과한 후(1차 침출액), 잔류물을 100% 이소프로판올 700ml에 넣어 24시간 냉침하여 여과하였다(2차 침출액). 1차 침출액과 2차 침출액을 합하여 감압농축하여 240ml의 1차 농축액을 얻었다. 1차 농축액에 제올라이트, 활성탄 혼합물(제올라이트 : 활성탄 = 1 : 1) 0.4g을 넣고 4시간 교반하여 여과한 후, 감압농축하여 약 5g의 연조엑스를 얻었다. 제올라이트는 비표면적 403m2/g, 미세세공 면적 241m2/g, Si/Al 분자비 25인 제올라이트를 사용하였다. 활성탄은 비표면적 1,200m2/g, 입경 74um 이하(200mesh 이상)인 활성탄을 사용하였다.100 g of chopped ae leaves were cooled with 1,700 ml of 100% isopropanol at room temperature for 24 hours and filtered (first leachate). The primary leachate and the secondary leachate were combined and concentrated under reduced pressure to obtain 240ml of the primary concentrate. 0.4 g of a mixture of zeolite and activated carbon (zeolite: activated carbon = 1:1) was added to the primary concentrate, stirred for 4 hours, filtered, and then concentrated under reduced pressure to obtain about 5 g of soft crude extract. As the zeolite, a zeolite having a specific surface area of 403 m 2 /g, a micropore area of 241 m 2 /g, and a Si/Al molecular ratio of 25 was used. Activated carbon having a specific surface area of 1,200 m 2 /g and a particle size of 74um or less (200mesh or more) was used.

실시예 3) 제올라이트, 활성탄 혼합물 4%를 처리한 추출물의 제조Example 3) Preparation of extract treated with zeolite and activated carbon mixture 4%

세절한 애엽 100g을 100% 이소프로판올 1,700ml으로 상온에서 24시간 냉침하여 여과한 후(1차 침출액), 잔류물을 100% 이소프로판올 700ml에 넣어 24시간 냉침하여 여과하였다(2차 침출액). 1차 침출액과 2차 침출액을 합하여 감압농축하여 240ml의 1차 농축액을 얻었다. 1차 농축액에 제올라이트, 활성탄 혼합물(제올라이트 : 활성탄 = 1 : 1) 4g을 넣고 4시간 교반하여 여과한 후, 감압농축하여 약 5g의 연조엑스를 얻었다. 제올라이트는 비표면적 403m2/g, 미세세공 면적 241m2/g, Si/Al 분자비 25인 제올라이트를 사용하였다. 활성탄은 비표면적 1,200m2/g, 입경 74um 이하(200mesh 이상)인 활성탄을 사용하였다.100 g of minced ae leaves were cooled with 1,700 ml of 100% isopropanol at room temperature for 24 hours and filtered (first leachate). The primary leachate and the secondary leachate were combined and concentrated under reduced pressure to obtain 240ml of the primary concentrate. 4 g of a mixture of zeolite and activated carbon (zeolite: activated carbon = 1:1) was added to the primary concentrate, stirred for 4 hours, filtered, and then concentrated under reduced pressure to obtain about 5 g of soft crude extract. As the zeolite, a zeolite having a specific surface area of 403 m 2 /g, a micropore area of 241 m 2 /g, and a Si/Al molecular ratio of 25 was used. Activated carbon having a specific surface area of 1,200 m 2 /g and a particle size of 74um or less (200mesh or more) was used.

실시예 4) 제올라이트, 활성탄 혼합물 40%를 처리한 추출물의 제조Example 4) Preparation of an extract treated with 40% of a mixture of zeolite and activated carbon

세절한 애엽 100g을 100% 이소프로판올 1,700ml으로 상온에서 24시간 냉침하여 여과한 후(1차 침출액), 잔류물을 100% 이소프로판올 700ml에 넣어 24시간 냉침하여 여과하였다(2차 침출액). 1차 침출액과 2차 침출액을 합하여 감압농축하여 240ml의 1차 농축액을 얻었다. 1차 농축액에 제올라이트, 활성탄 혼합물(제올라이트 : 활성탄 = 1 : 1) 40g을 넣고 4시간 교반하여 여과한 후, 감압농축하여 약 5g의 연조엑스를 얻었다. 제올라이트는 비표면적 403m2/g, 미세세공 면적 241m2/g, Si/Al 분자비 25인 제올라이트를 사용하였다. 활성탄은 비표면적 1,200m2/g, 입경 74um 이하(200mesh 이상)인 활성탄을 사용하였다.100 g of chopped ae leaves were cooled with 1,700 ml of 100% isopropanol at room temperature for 24 hours and filtered (first leachate). The primary leachate and the secondary leachate were combined and concentrated under reduced pressure to obtain 240ml of the primary concentrate. 40 g of a mixture of zeolite and activated carbon (zeolite: activated carbon = 1:1) was added to the primary concentrate, stirred for 4 hours, filtered, and then concentrated under reduced pressure to obtain about 5 g of soft crude extract. As the zeolite, a zeolite having a specific surface area of 403 m 2 /g, a micropore area of 241 m 2 /g, and a Si/Al molecular ratio of 25 was used. Activated carbon with a specific surface area of 1,200 m 2 /g and a particle size of 74um or less (200mesh or more) was used.

실시예 5) 제올라이트, 활성탄 혼합물이 0.4% 충진된 컬럼을 사용한 추출물의 제조Example 5) Preparation of extract using a column filled with a mixture of zeolite and activated carbon 0.4%

세절한 애엽 100g을 100% 이소프로판올 1,700ml으로 상온에서 24시간 냉침하여 여과한 후(1차 침출액), 잔류물을 100% 이소프로판올 700ml에 넣어 24시간 냉침하여 여과하였다(2차 침출액). 1차 침출액과 2차 침출액을 합하여 감압농축하여 240ml의 1차 농축액을 얻었다. 1차 농축액을 제올라이트, 활성탄 각 0.2g씩 혼합되어 충진된 컬럼에 연속 순환 여과한 후, 감압농축하여 약 5g의 연조엑스를 얻었다. 제올라이트는 비표면적 403m2/g, 미세세공 면적 241m2/g, Si/Al 분자비 25인 제올라이트를 사용하였다. 활성탄은 비표면적 1,200m2/g, 입경 74um 이하(200mesh 이상)인 활성탄을 사용하였다.100 g of minced ae leaves were cooled with 1,700 ml of 100% isopropanol at room temperature for 24 hours and filtered (first leachate). The primary leachate and the secondary leachate were combined and concentrated under reduced pressure to obtain 240ml of the primary concentrate. The primary concentrate was mixed with 0.2 g each of zeolite and activated carbon, filtered through continuous circulation in a column packed, and then concentrated under reduced pressure to obtain about 5 g of soft crude extract. As the zeolite, a zeolite having a specific surface area of 403 m 2 /g, a micropore area of 241 m 2 /g, and a Si/Al molecular ratio of 25 was used. Activated carbon having a specific surface area of 1,200 m 2 /g and a particle size of 74um or less (200mesh or more) was used.

실시예 6) 원생약을 세척한 후, 제올라이트, 활성탄 혼합물 0.4%를 처리한 추출물의 제조Example 6) Preparation of extract treated with 0.4% of a mixture of zeolite and activated carbon after washing the protozoan

세절한 애엽 100g을 미온수에 담가 세척한 후, 40℃에서 송풍 건조 시킨다. 건조된 애엽을 100% 이소프로판올 1,700ml으로 상온에서 24시간 냉침하여 여과한 후(1차 침출액), 잔류물을 100% 이소프로판올 700ml에 넣어 24시간 냉침하여 여과하였다(2차 침출액). 1차 침출액과 2차 침출액을 합하여 감압농축하여 240ml의 1차 농축액을 얻었다. 1차 농축액에 제올라이트, 활성탄 혼합물(제올라이트 : 활성탄 = 1 : 1) 0.4g을 넣고 4시간 교반하여 여과한 후, 감압농축하여 약 5g의 연조엑스를 얻었다. 제올라이트는 비표면적 403m2/g, 미세세공 면적 241m2/g, Si/Al 분자비 25인 제올라이트를 사용하였다. 활성탄은 비표면적 1,200m2/g, 입경 74um 이하(200mesh 이상)인 활성탄을 사용하였다.100g of chopped ae leaves are soaked in lukewarm water, washed, and blow-dried at 40°C. The dried ae leaves were cooled with 1,700 ml of 100% isopropanol at room temperature for 24 hours and filtered (first leachate). The primary leachate and the secondary leachate were combined and concentrated under reduced pressure to obtain 240ml of the primary concentrate. 0.4 g of a mixture of zeolite and activated carbon (zeolite: activated carbon = 1:1) was added to the primary concentrate, stirred for 4 hours, filtered, and then concentrated under reduced pressure to obtain about 5 g of soft crude extract. As the zeolite, a zeolite having a specific surface area of 403 m 2 /g, a micropore area of 241 m 2 /g, and a Si/Al molecular ratio of 25 was used. Activated carbon having a specific surface area of 1,200 m 2 /g and a particle size of 74um or less (200mesh or more) was used.

실시예 7) 제올라이트, 활성탄 혼합물 0.4%를 처리한 추출물의 제조Example 7) Preparation of extract treated with zeolite and activated carbon mixture 0.4%

세절한 애엽 100g을 100% 이소프로판올 1,700ml으로 상온에서 24시간 냉침하여 여과한 후(1차 침출액), 잔류물을 100% 이소프로판올 700ml에 넣어 24시간 냉침하여 여과하였다(2차 침출액). 1차 침출액과 2차 침출액을 합하여 감압농축하여 240ml의 1차 농축액을 얻었다. 1차 농축액에 제올라이트, 활성탄 혼합물(제올라이트 : 활성탄 = 1 : 5) 0.4g을 넣고 4시간 교반하여 여과한 후, 감압농축하여 약 5g의 연조엑스를 얻었다. 제올라이트는 비표면적 403m2/g, 미세세공 면적 241m2/g, Si/Al 분자비 25인 제올라이트를 사용하였다. 활성탄은 비표면적 1,200m2/g, 입경 74um 이하(200mesh 이상)인 활성탄을 사용하였다.100 g of minced ae leaves were cooled with 1,700 ml of 100% isopropanol at room temperature for 24 hours and filtered (first leachate). The primary leachate and the secondary leachate were combined and concentrated under reduced pressure to obtain 240ml of the primary concentrate. 0.4 g of a mixture of zeolite and activated carbon (zeolite: activated carbon = 1: 5) was added to the primary concentrate, stirred for 4 hours, filtered, and then concentrated under reduced pressure to obtain about 5 g of soft crude extract. As the zeolite, a zeolite having a specific surface area of 403 m 2 /g, a micropore area of 241 m 2 /g, and a Si/Al molecular ratio of 25 was used. Activated carbon having a specific surface area of 1,200 m 2 /g and a particle size of 74um or less (200mesh or more) was used.

실시예 8) 제올라이트, 활성탄 혼합물 0.4%를 처리한 추출물의 제조Example 8) Preparation of extract treated with zeolite and activated carbon mixture 0.4%

세절한 애엽 100g을 100% 이소프로판올 1,700ml으로 상온에서 24시간 냉침하여 여과한 후(1차 침출액), 잔류물을 100% 이소프로판올 700ml에 넣어 24시간 냉침하여 여과하였다(2차 침출액). 1차 침출액과 2차 침출액을 합하여 감압농축하여 240ml의 1차 농축액을 얻었다. 1차 농축액에 제올라이트, 활성탄 혼합물(제올라이트 : 활성탄 = 5 : 1) 0.4g을 넣고 4시간 교반하여 여과한 후, 감압농축하여 약 5g의 연조엑스를 얻었다. 제올라이트는 비표면적 403m2/g, 미세세공 면적 241m2/g, Si/Al 분자비 25인 제올라이트를 사용하였다. 활성탄은 비표면적 1,200m2/g, 입경 74um 이하(200 mesh 이상)인 활성탄을 사용하였다.100 g of minced ae leaves were cooled with 1,700 ml of 100% isopropanol at room temperature for 24 hours and filtered (first leachate). The primary leachate and the secondary leachate were combined and concentrated under reduced pressure to obtain 240ml of the primary concentrate. 0.4 g of a mixture of zeolite and activated carbon (zeolite: activated carbon = 5: 1) was added to the primary concentrate, stirred for 4 hours, filtered, and then concentrated under reduced pressure to obtain about 5 g of soft crude extract. As the zeolite, a zeolite having a specific surface area of 403 m 2 /g, a micropore area of 241 m 2 /g, and a Si/Al molecular ratio of 25 was used. Activated carbon having a specific surface area of 1,200 m 2 /g and a particle diameter of 74 μm or less (200 mesh or more) was used as the activated carbon.

실험예 1) 제올라이트 또는 활성탄 투여량에 따른 벤조피렌 저감 및 지표성분 함량 평가Experimental Example 1) benzopyrene reduction and index component content evaluation according to the dose of zeolite or activated carbon

제올라이트 또는 활성탄 투입량에 따른 벤조피렌 저감 효과와 지표성분 함량 변화를 확인하기 위해 제올라이트 또는 활성탄의 투여량을 달리하여 처리한 이소프로판올 애엽 추출물을 비교 평가하였다. 활성탄을 처리하지 않은 비교예 1을 대조군으로 하였다. 각각의 추출물은 고속액체크로마토그래피를 이용하여 평가하였다.In order to confirm the effect of reducing benzopyrene according to the amount of zeolite or activated carbon and the change in the content of the indicator component, isopropanol aerobium extract treated with different doses of zeolite or activated carbon was comparatively evaluated. Comparative Example 1 not treated with activated carbon was used as a control. Each extract was evaluated using high performance liquid chromatography.

처리군treatment group 흡착제absorbent 원생약 대비 흡착제 투입량(%)Adsorbent input amount compared to crude drug (%) 대조군 대비compared to control 벤조피렌(%)Benzopyrene (%) 유파틸린(%)Eupatylline (%) 자세오시딘(%)Zeiocidin (%) 비교예 1Comparative Example 1 미처리unprocessed 미처리unprocessed 100100 100100 100100 비교예 2Comparative Example 2 제올라이트zeolite 0.020.02 7272 100100 9999 비교예 3Comparative Example 3 0.20.2 5959 9898 100100 비교예 4Comparative Example 4 22 4848 9999 9999 비교예 5Comparative Example 5 2020 4747 9898 9999 비교예 6Comparative Example 6 4040 4747 9797 9898 비교예 7Comparative Example 7 활성탄activated carbon 0.020.02 3737 9898 9898 비교예 8Comparative Example 8 0.20.2 2626 9696 9595 비교예 9Comparative Example 9 22 1414 9090 9191 비교예 10Comparative Example 10 1010 1010 8080 8080 비교예 11Comparative Example 11 4040 00 5252 5151

제올라이트 0.02~40%(w/w) 처리 시, 2%(w/w) 이상 처리군에서 벤조피렌 잔류율이 더 이상 감소하지 않았으며, 지표성분인 유파틸린과 자세오시딘의 함량은 큰 변화가 없었다.When zeolite was treated with 0.02 to 40% (w/w), the benzopyrene residual rate did not decrease any more in the group treated with 2% (w/w) or more, and the contents of eupatylin and zeosidine, which are index components, showed no significant change. there was no

활성탄 0.02~40%(w/w) 처리 시, 투여량이 늘어날수록 벤조피렌 잔류율이 감소하였으며, 지표성분인 유파틸린과 자세오시딘의 경우 20%(w/w) 초과 처리군에서 큰 함량변화를 나타냈다. 활성탄 처리군의 경우, 제올라이트 처리군에 비해 벤조피렌 저감 효과가 높았다.When the activated carbon was treated with 0.02-40% (w/w), the benzopyrene residual rate decreased as the dose increased, and in the case of eupatylin and zeosidine, which are indicator ingredients, a large content change was observed in the treatment group exceeding 20% (w/w). showed In the case of the activated carbon-treated group, the benzopyrene reduction effect was higher than that of the zeolite-treated group.

실험예 2) 제올라이트와 활성탄 혼합에 따른 벤조피렌 저감 및 지표성분 함량 평가Experimental Example 2) benzopyrene reduction and index component content evaluation by mixing zeolite and activated carbon

제올라이트와 활성탄 혼합에 따른 벤조피렌 저감 효과와 지표성분 함량 변화를 확인하기 위해 제올라이트와 활성탄의 혼합에 따른 비교 평가를 시행하였다. 제올라이트 또는 활성탄을 처리하지 않은 비교예 1을 대조군으로 하였다. 각각의 추출물은 고속액체크로마토그래피를 이용하여 평가하였다.A comparative evaluation was performed according to the mixing of zeolite and activated carbon in order to confirm the effect of reducing benzopyrene and the change in the content of index components according to the mixing of zeolite and activated carbon. Comparative Example 1 not treated with zeolite or activated carbon was used as a control. Each extract was evaluated using high performance liquid chromatography.

처리군treatment group 흡착제absorbent 원생약 대비 흡착제 투입량(%)Adsorbent input amount compared to crude drug (%) 대조군 대비compared to control 벤조피렌(%)Benzopyrene (%) 유파틸린(%)Eupatylline (%) 자세오시딘(%)Zeiocidin (%) 비교예 1Comparative Example 1 미처리unprocessed 미처리unprocessed 100100 100100 100100 비교예 7Comparative Example 7 활성탄activated carbon 0.020.02 3737 9898 9898 비교예 8Comparative Example 8 0.20.2 2626 9696 9595 비교예 9Comparative Example 9 22 1414 9090 9191 비교예 10Comparative Example 10 1010 1010 8080 8080 비교예 11Comparative Example 11 4040 00 5252 5151 실시예 1Example 1 제올라이트와 활성탄 혼합물Zeolite and activated carbon mixture 0.040.04 44 9999 9898 실시예 2Example 2 0.40.4 00 9696 9696 실시예 3Example 3 44 00 9191 9191 실시예 4Example 4 4040 00 8080 8181 비교예 12Comparative Example 12 8080 00 5151 5050

제올라이트와 활성탄 혼합물에서 활성탄 단일 처리에 비해 벤조피렌 저감 효과가 현저히 증가하였으며, 80%(w/w)를 제외한 모든 처리군에서 지표성분인 유파틸린과 자세오시딘의 큰 함량변화가 없었다. 특히, 제올라이트와 활성탄 혼합물 0.4%(w/w) 처리군에서 지표성분인 유파틸린과 자세오시딘의 큰 함량변화 없이 벤조피렌이 현저히 제거되었다.In the mixture of zeolite and activated carbon, the effect of reducing benzopyrene was significantly increased compared to the single treatment of activated carbon, and there was no significant change in the contents of eupatylin and zeosidine, which are index components, in all treatment groups except 80% (w/w). In particular, in the 0.4% (w/w) treatment group of a mixture of zeolite and activated carbon, benzopyrene was significantly removed without significant change in the content of eupatylline and zeosidine, which are index components.

실험예 3) 컬럼 사용에 의한 벤조피렌 저감 및 지표성분 함량 평가Experimental Example 3) Reduction of benzopyrene by using a column and evaluation of index component content

제올라이트와 활성탄 혼합물이 충진된 컬럼에 순환 여과를 하여 벤조피렌 저감 효과와 지표성분 함량 변화를 확인하였다. 또한, 원생약 세척 건조 후 활성탄 또는 제올라이트와 활성탄 혼합물 처리 시 벤조피렌 저감 효과와 지표성분 함량 변화를 확인하였다. 제올라이트 또는 활성탄을 처리하지 않은 비교예 1을 대조군으로 하였다. 각각의 추출물은 고속액체크로마토그래피를 이용하여 평가하였다.Circulation filtration was performed on a column filled with a mixture of zeolite and activated carbon to confirm the effect of reducing benzopyrene and change in the content of indicator components. In addition, the benzopyrene reduction effect and the change in the content of the indicator components were confirmed when the activated carbon or a mixture of zeolite and activated carbon was treated after washing and drying of the probiotic. Comparative Example 1 not treated with zeolite or activated carbon was used as a control. Each extract was evaluated using high performance liquid chromatography.

처리군treatment group 흡착제absorbent 원생약 대비 흡착제 투입량(%)Adsorbent input amount compared to crude drug (%) 대조군 대비compared to control 벤조피렌(%)Benzopyrene (%) 유파틸린(%)Eupatylline (%) 자세오시딘(%)Zeiocidin (%) 비교예 1Comparative Example 1 미처리unprocessed 미처리unprocessed 100100 100100 100100 비교예 8Comparative Example 8 활성탄activated carbon 0.20.2 2626 9696 9595 실시예 2Example 2 제올라이트와 활성탄 혼합물Zeolite and activated carbon mixture 0.40.4 00 9696 9696 실시예 5Example 5 제올라이트, 활성탄 컬럼Zeolite, activated carbon column 0.40.4 00 9595 9696 비교예 13Comparative Example 13 원생약 세척Probiotic cleaning 미처리unprocessed 7676 100100 100100 비교예 14Comparative Example 14 원생약 세척 후 활성탄Activated carbon after washing the raw material 0.20.2 2020 9595 9595 실시예 6Example 6 원생약 세척 후 제올라이트와 활성탄 혼합물A mixture of zeolite and activated carbon after washing the protozoan 0.40.4 00 9696 9595

제올라이트와 활성탄 혼합물이 충진된 컬럼에 순환 여과를 할 경우, 이는 제올라이트와 활성탄 혼합물을 처리할 때와 동등한 수준의 벤조피렌 저감 효과를 나타냈으며, 지표성분인 유파틸린과 자세오시딘의 함량변화가 크게 없었다.When circulation filtration was performed on a column filled with a mixture of zeolite and activated carbon, it exhibited an effect of reducing benzopyrene at the same level as when treating a mixture of zeolite and activated carbon, and there was no significant change in the contents of eupatylin and zeosidine, which are index components. .

원생약 세척 건조 시, 미처리에 비해 벤조피렌 잔류율이 76%로 감소하였지만, 제올라이트와 활성탄 혼합물을 처리할 경우 세척, 미세척과 상관없이 동등한 벤조피렌 저감 효과를 보였다.When the crude drug was washed and dried, the residual rate of benzopyrene was reduced to 76% compared to untreated, but when the mixture of zeolite and activated carbon was treated, the same benzopyrene reduction effect was shown regardless of washing or unwashing.

실험예 4) 제올라이트와 활성탄 물성에 따른 벤조피렌 저감 및 지표성분 함량 평가Experimental Example 4) benzopyrene reduction and index component content evaluation according to the physical properties of zeolite and activated carbon

제올라이트와 활성탄 물성에 따른 벤조피렌 저감 효과와 지표성분 함량 변화를 확인하였다.제올라이트 또는 활성탄을 처리하지 않은 비교예 1을 대조군으로 하였다. 각각의 추출물은 고속액체크로마토그래피를 이용하여 평가하였다.The effect of reducing benzopyrene and changes in the content of index components according to the physical properties of zeolite and activated carbon were confirmed. Comparative Example 1, which was not treated with zeolite or activated carbon, was used as a control group. Each extract was evaluated using high performance liquid chromatography.

처리군treatment group 흡착제absorbent 원생약 대비 흡착제 투입량(%)Adsorbent input amount compared to crude drug (%) 대조군 대비compared to control 벤조피렌(%)Benzopyrene (%) 유파틸린(%)Eupatylline (%) 자세오시딘(%)Zeiocidin (%) 비교예 1Comparative Example 1 미처리unprocessed 미처리unprocessed 100100 100100 100100 비교예 3Comparative Example 3 제올라이트zeolite 0.20.2 5959 9898 100100 비교예 15Comparative Example 15 9898 9999 100100 비교예 8Comparative Example 8 활성탄activated carbon 0.20.2 2626 9696 9595 비교예 16Comparative Example 16 8888 9898 9999 실시예 2Example 2 제올라이트와 활성탄 혼합물Zeolite and activated carbon mixture 0.40.4 00 9696 9696 비교예 17Comparative Example 17 8989 9999 9898

비교예는 실시예에 비해서 벤조피렌 저감 효과가 크게 떨어진 것을 확인하였다.The comparative example confirmed that the benzopyrene reduction effect was significantly lower than that of the Example.

실험예 5) 제올라이트와 활성탄 혼합비에 따른 벤조피렌 저감 및 지표성분 함량 평가Experimental Example 5) benzopyrene reduction and index component content evaluation according to the mixing ratio of zeolite and activated carbon

제올라이트과 활성탄 혼합비에 따른 벤조피렌 저감 효과와 지표성분 함량 변화를 확인하기 위해 제올라이트와 활성탄의 혼합비에 따른 비교 평가를 시행하였다. 제올라이트 또는 활성탄을 처리하지 않은 비교예 1을 대조군으로 하였다. 각각의 추출물은 고속액체크로마토그래피를 이용하여 평가하였다.A comparative evaluation was performed according to the mixing ratio of zeolite and activated carbon to confirm the effect of reducing benzopyrene and the change in the content of index components according to the mixing ratio of zeolite and activated carbon. Comparative Example 1 not treated with zeolite or activated carbon was used as a control. Each extract was evaluated using high performance liquid chromatography.

처리군treatment group 흡착제absorbent 원생약 대비 흡착제 투입량(%)Adsorbent input amount compared to raw drug (%) 혼합비mixing ratio 대조군 대비compared to control 벤조피렌(%)Benzopyrene (%) 유파틸린(%)Eupatylline (%) 자세오시딘(%)Zeiocidin (%) 비교예 1Comparative Example 1 미처리unprocessed 미처리unprocessed -- 100100 100100 100100 비교예 8Comparative Example 8 활성탄activated carbon 0.20.2 -- 2626 9696 9595 실시예 7Example 7 제올라이트와 활성탄 혼합물Zeolite and activated carbon mixture 0.40.4 1 : 51: 5 00 9696 9595 실시예 8Example 8 5 : 15 : 1 00 9797 9797 실시예 2Example 2 1 : 11:1 00 9696 9696

제올라이트, 활성탄 1 : 5 ~ 5 : 1 혼합비에서 활성탄 단일 처리에 비해 벤조피렌 저감 효과가 현저히 증가하였다.At a mixing ratio of zeolite and activated carbon of 1: 5 to 5: 1, the effect of reducing benzopyrene was significantly increased compared to the single treatment of activated carbon.

실험예 6) 위병변 억제 효과 평가Experimental Example 6) Gastric lesion inhibitory effect evaluation

각 실시예에 따른 애엽 추출물에 대해 위장질환 치료 효과를 평가하였다. 활성탄과 제올라이트를 처리하지 않은 비교예 1을 대조군으로 하였다. 위장질환 치료 효과를 평가하기 위한 동물 모델은 염산-에탄올 유발 위 손상 랫드 모델을 사용하였으며, 위병변율 측정을 통하여 치료 효과를 평가하였다.Gastrointestinal disease treatment effect was evaluated for the aeyeop extract according to each example. Comparative Example 1 in which activated carbon and zeolite were not treated was used as a control. As an animal model for evaluating the treatment effect of gastrointestinal diseases, a hydrochloric acid-ethanol-induced gastric injury rat model was used, and the treatment effect was evaluated by measuring the rate of gastric lesions.

처리군treatment group 흡착제absorbent 원생약 대비 흡착제 투입량(%)Adsorbent input amount compared to raw drug (%) 동물수number of animals 질환 유도군 대비
위병변 면적(%)
compared to the disease-inducing group
Stomach lesion area (%)
질환 유도군disease induction group -- -- 1010 100100 비교예 1Comparative Example 1 미처리unprocessed 미처리unprocessed 1010 14** 14** 실시예 1Example 1 제올라이트와 활성탄 혼합물Zeolite and activated carbon mixture 0.040.04 1010 15** 15** 실시예 2Example 2 0.40.4 1010 14** 14** 실시예 3Example 3 44 1010 13** 13** 실시예 4Example 4 4040 1010 13** 13** 비교예 12Comparative Example 12 8080 1010 48 48 실시예 5Example 5 제올라이트, 활성탄 컬럼Zeolite, Activated Carbon Column 0.40.4 1010 14** 14**

** 질환유도군 대비 통계적 유의성(P<0.01)
** Statistical significance compared to disease induction group (P<0.01)

표 6에서 알 수 있는 바와 같이, 비교예 12는 벤조피렌의 양은 모두 제거시킬 수 있으나, 유효성분인 유파틸린, 자세오시딘 역시 큰 함량변화를 나타내어 위출혈병변 억제효과가 미미하였다. 제올라이트와 활성탄 혼합물을 40%(w/w) 이하로 사용한 실시예 1 내지 4와 제올라이트와 활성탄 혼합물이 충진된 컬럼에 순환 여과한 실시예 5는 위출혈병변 억제 효과가 활성탄 미처리군 대비 차이가 없음을 알 수 있었다. 따라서, 본 발명은 원생약 대비 제올라이트와 활성탄 혼합물을 0.04%(w/w) 내지 40%(w/w) 사용하거나 제올라이트와 활성탄 혼합물이 충진된 컬럼에 순환 여과 경우, 제올라이트·활성탄 혼합물 미처리군 대비 유해물질인 벤조피렌을 저감시키면서 동등한 정도의 애엽 추출물의 위출혈병변 억제 효과를 나타냄을 알 수 있다.As can be seen from Table 6, Comparative Example 12 can remove all of the amount of benzopyrene, but the active ingredients eupatylline and zeosidine also showed a large content change, so the effect of inhibiting gastric bleeding lesions was insignificant. Examples 1 to 4 using a mixture of zeolite and activated carbon at 40% (w/w) or less and Example 5, in which a column filled with a mixture of zeolite and activated carbon was filtered through circulation, showed no difference in the effect of inhibiting gastric bleeding lesion compared to the activated carbon untreated group Could know. Therefore, the present invention uses 0.04% (w/w) to 40% (w/w) of a zeolite and activated carbon mixture compared to the protozoan, or in the case of circulation filtration in a column filled with a zeolite and activated carbon mixture, compared to the zeolite-activated carbon mixture untreated group It can be seen that while reducing benzopyrene, which is a harmful substance, the aeyeop extract exhibits an effect of inhibiting gastric bleeding lesions to the same extent.

실험예 7) 추출물의 성분 프로파일 동등성 평가Experimental Example 7) Evaluation of component profile equivalence of extracts

제올라이트와 활성탄 혼합물 처리 시, 추출물의 성분 프로파일이 변화하는지 확인하기 위해 미처리 추출물 간 비교 평가하였다. 그 결과를 하기 표 7에 나타냈다.When the mixture of zeolite and activated carbon was treated, comparison between untreated extracts was evaluated to determine whether the component profile of the extract was changed. The results are shown in Table 7 below.

구분division RTRT AreaArea Correlation coefficientcorrelation coefficient 0.99990.9999 0.98200.9820

동등 상관계수가 0.9 이상으로 제올라이트와 활성탄 혼합물 미처리 시와 처리 시에 따른 추출물의 성분 프로파일이 동등하였다.The equicorrelation coefficient was 0.9 or more, and the component profiles of the extracts were the same when the mixture of zeolite and activated carbon was not treated and when treated.

본 발명에 의하여 벤조피렌이 저감된 애엽 추출물을 제조할 수 있다.According to the present invention, it is possible to prepare an ayeop extract with reduced benzopyrene.

Claims (7)

활성탄 및 제올라이트의 혼합물을 이용하여 애엽 추출물의 벤조피렌을 저감시키는 방법.A method for reducing benzopyrene in Ayeop extract using a mixture of activated carbon and zeolite. 제 1항에 있어서, 상기 혼합물 중 활성탄 : 제올라이트의 혼합비가 1:5~5:1인 것을 특징으로 하는 방법.The method according to claim 1, wherein a mixing ratio of activated carbon to zeolite in the mixture is 1:5-5:1. 제 1항 또는 제 2항에 있어서, 상기 혼합물을 애엽 추출물에 넣어 교반하는 것을 특징으로 하는 방법.[3] The method according to claim 1 or 2, wherein the mixture is added to the aerobium extract and stirred. 제 1항 또는 제 2항에 있어서, 상기 혼합물을 컬럼에 충진하여 사용하는 것을 특징으로 하는 방법.The method according to claim 1 or 2, wherein the mixture is used by filling a column. 제 1항 또는 제 2항에 있어서, 상기 혼합물을 애엽의 중량대비 0.04~40%(w/w) 사용하는 것을 특징으로 하는 방법.The method according to claim 1 or 2, wherein the mixture is used in an amount of 0.04 to 40% (w/w) based on the weight of the leaf. 제 5항에 있어서, 상기 혼합물을 애엽의 중량대비 0.4~4%(w/w) 사용하는 것을 특징으로 하는 방법.The method according to claim 5, wherein the mixture is used in an amount of 0.4 to 4% (w/w) based on the weight of the leaf. 애엽을 에탄올 또는 이소프로판올로 추출하여 애엽 추출물을 제조하는 방법으로서, 제 1항 또는 제 2항에 규정된 방법을 포함하는 것을 특징으로 하는 애엽 추출물의 제조방법.A method for preparing an ayeop extract by extracting the aeyeop with ethanol or isopropanol, comprising the method defined in claim 1 or 2, for producing an aeyeop extract.
KR1020150181739A 2015-12-18 2015-12-18 A method for preparing artemisia extract with a reduced content of benzopyrene KR102414382B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020150181739A KR102414382B1 (en) 2015-12-18 2015-12-18 A method for preparing artemisia extract with a reduced content of benzopyrene

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020150181739A KR102414382B1 (en) 2015-12-18 2015-12-18 A method for preparing artemisia extract with a reduced content of benzopyrene

Publications (2)

Publication Number Publication Date
KR20170073780A KR20170073780A (en) 2017-06-29
KR102414382B1 true KR102414382B1 (en) 2022-06-30

Family

ID=59280315

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020150181739A KR102414382B1 (en) 2015-12-18 2015-12-18 A method for preparing artemisia extract with a reduced content of benzopyrene

Country Status (1)

Country Link
KR (1) KR102414382B1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20220152079A (en) 2021-05-07 2022-11-15 송찬영 Body count control beehive

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007515272A (en) 2003-12-22 2007-06-14 エニテクノロジー、ソシエタ、ペル、アチオニ Contaminated water treatment method based on the use of nonpolar zeolite with different properties

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101021088B1 (en) * 2007-06-05 2011-03-14 주식회사 젠트로 A method for refining wood vinegar, refined wood vinegar thereby, and cosmetic, and mouth freshener containing the refined wood vinegar
KR20150085330A (en) 2014-01-15 2015-07-23 동아에스티 주식회사 A method for preparing artemisia extract with a reduced content of hazardous substance for treatment of gastrointestinal disorders

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007515272A (en) 2003-12-22 2007-06-14 エニテクノロジー、ソシエタ、ペル、アチオニ Contaminated water treatment method based on the use of nonpolar zeolite with different properties

Also Published As

Publication number Publication date
KR20170073780A (en) 2017-06-29

Similar Documents

Publication Publication Date Title
KR100543862B1 (en) A black ginseng having excel content of active ingredient and the concentrate of black ginseng
KR100600795B1 (en) A black ginseng having excel content of ginsenoside rg3 ingredient and the concentrate of black ginseng
JP2010120939A (en) Method for producing fucoxanthin-containing extract
CN106615643A (en) Antimycotoxicgenic feed additive for poultry as well as preparation method and application of antimycotoxicgenic feed additive
CN111419947A (en) Folium artemisiae argyi compound essential oil capable of relieving throat pain and preparation method thereof
KR102414382B1 (en) A method for preparing artemisia extract with a reduced content of benzopyrene
KR20170085451A (en) Composition for eliminating hangover
KR102102295B1 (en) Composition comprising compound K and decursinol for extending life span and stimulating differentiation of cells
KR102124507B1 (en) Composition comprising compound K and decursinol for preventing or treating for dementia
JPS6154389B2 (en)
RU2533040C2 (en) Composition for phytojam preparation (versions)
KR20150085330A (en) A method for preparing artemisia extract with a reduced content of hazardous substance for treatment of gastrointestinal disorders
CN104491499A (en) Skin-care powder with efficacy of removing scars and acne marks
CN108497246A (en) A kind of plant weight losing function beverage and preparation method thereof
KR100803375B1 (en) Neutralizing agent for cavitating toxin
KR20130085935A (en) A composition comprising an extract fraction having enhanced content of ginsenoside rg3 from ginseng radix for improving convergency and memory capacity
KR100640190B1 (en) Preventer of nicotine and preparation method thereof
CN102210796B (en) Medicament for treating chicken colibacillosis and preparation method thereof
CN110786442A (en) Method for reducing bioavailability and toxicity of cadmium in food
RU2637128C1 (en) Birch extract with medicinal plant decoctions
CN104706831A (en) Taxus chinensis antibacterial lotion and production technologic method thereof
KR101763670B1 (en) Pharmaceutical composition for treatment of contusion comprising Rehmanniae Radix preparata faction
KR101684356B1 (en) Solid formulation comprsing oily extract from pine needles, method of preparation the same, and edible salt comprising the same
KR101322244B1 (en) The manufacturing method of mixed beverages having cypress extract
CN107456504A (en) A kind of dietary supplements and its preparation method and application

Legal Events

Date Code Title Description
A201 Request for examination
E701 Decision to grant or registration of patent right